MedTrace Logo

The Bleeding With Antithrombotic Therapy Study 2

NCT02889653 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5306

Last updated 2023-11-09

No results posted yet for this study

Summary

The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy.

Conditions

  • Cerebrovascular and Cardiovascular Diseases

Interventions

DRUG

Any oral antithrombotics (antiplatelets or anticoagulants)

Sponsors & Collaborators

  • Japan Agency for Medical Research and Development

    collaborator OTHER_GOV

  • National Cerebral and Cardiovascular Center, Japan

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2020-03-31
Completion
2021-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02889653 on ClinicalTrials.gov